These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 19001190)

  • 41. Slowly progressing type 1 diabetes: persistence of islet cell autoantibodies is related to glibenclamide treatment.
    Cabrera-Rode E; Perich P; Diaz-Horta O; Tiberti C; Molina G; Arranz C; Martin JM; Licea M; De Leiva AD; Puig-Domingo M; Dimario U
    Autoimmunity; 2002 Nov; 35(7):469-74. PubMed ID: 12685875
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevalence of LADA and frequency of GAD antibodies in diabetic patients with end-stage renal disease and dialysis treatment in Austria.
    Biesenbach G; Auinger M; Clodi M; Prischl F; Kramar R;
    Nephrol Dial Transplant; 2005 Mar; 20(3):559-65. PubMed ID: 15671073
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Management of Latent Autoimmune Diabetes in Adults: A Consensus Statement From an International Expert Panel.
    Buzzetti R; Tuomi T; Mauricio D; Pietropaolo M; Zhou Z; Pozzilli P; Leslie RD
    Diabetes; 2020 Oct; 69(10):2037-2047. PubMed ID: 32847960
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevalence of ZnT8 antibody in relation to phenotype and SLC30A8 polymorphism in adult autoimmune diabetes: results from the HUNT study, Norway.
    Sørgjerd EP; Skorpen F; Kvaløy K; Midthjell K; Grill V
    Autoimmunity; 2013 Feb; 46(1):74-9. PubMed ID: 23061550
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical and metabolic characteristics of patients with latent autoimmune diabetes in adults (LADA): absence of rapid beta-cell loss in patients with tight metabolic control.
    Chaillous L; Bouhanick B; Kerlan V; Mathieu E; Lecomte P; Ducluzeau PH; Delamaire M; Sonnet E; Maugendre D; Maréchaud R; Rohmer V; Saï P; Charbonnel B
    Diabetes Metab; 2010 Feb; 36(1):64-70. PubMed ID: 20060765
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Latent Autoimmune Diabetes in Adults in the United Arab Emirates: Clinical Features and Factors Related to Insulin-Requirement.
    Maddaloni E; Lessan N; Al Tikriti A; Buzzetti R; Pozzilli P; Barakat MT
    PLoS One; 2015; 10(8):e0131837. PubMed ID: 26252955
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Investigating optimal β-cell-preserving treatment in latent autoimmune diabetes in adults: Results from a 21-month randomized trial.
    Hals IK; Fiskvik Fleiner H; Reimers N; Astor MC; Filipsson K; Ma Z; Grill V; Björklund A
    Diabetes Obes Metab; 2019 Oct; 21(10):2219-2227. PubMed ID: 31148332
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Overweight, obesity and the risk of LADA: results from a Swedish case-control study and the Norwegian HUNT Study.
    Hjort R; Ahlqvist E; Carlsson PO; Grill V; Groop L; Martinell M; Rasouli B; Rosengren A; Tuomi T; Åsvold BO; Carlsson S
    Diabetologia; 2018 Jun; 61(6):1333-1343. PubMed ID: 29589073
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anti-CD38 autoantibodies: characterisation in new-onset type I diabetes and latent autoimmune diabetes of the adult (LADA) and comparison with other islet autoantibodies.
    Mallone R; Ortolan E; Pinach S; Volante M; Zanone MM; Bruno G; Baj G; Lohmann T; Cavallo-Perin P; Malavasi F
    Diabetologia; 2002 Dec; 45(12):1667-77. PubMed ID: 12488956
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Age, overweight and physical inactivity increase the risk of latent autoimmune diabetes in adults: results from the Nord-Trøndelag health study.
    Carlsson S; Midthjell K; Tesfamarian MY; Grill V
    Diabetologia; 2007 Jan; 50(1):55-8. PubMed ID: 17096113
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Optimal cutoff point of glutamate decarboxylase antibody titers in differentiating two subtypes of adult-onset latent autoimmune diabetes.
    Li X; Zhou ZG; Huang G; Yan X; Yang L; Chen XY; Wang JP
    Ann N Y Acad Sci; 2004 Dec; 1037():122-6. PubMed ID: 15699504
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fatty Acid Profiles and Their Association With Autoimmunity, Insulin Sensitivity and β Cell Function in Latent Autoimmune Diabetes in Adults.
    Tian H; Wang S; Deng Y; Xing Y; Zhao L; Zhang X; Zhang P; Liu N; Su B
    Front Endocrinol (Lausanne); 2022; 13():916981. PubMed ID: 35846301
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of Latent Autoimmune Diabetes in Adults: What is Best?
    Hals IK
    Curr Diabetes Rev; 2019; 15(3):188-193. PubMed ID: 30009709
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Influence of family history of diabetes on incidence and prevalence of latent autoimmune diabetes of the adult: results from the Nord-Trøndelag Health Study.
    Carlsson S; Midthjell K; Grill V
    Diabetes Care; 2007 Dec; 30(12):3040-5. PubMed ID: 17878245
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adult-onset autoimmune diabetes: current knowledge and implications for management.
    Buzzetti R; Zampetti S; Maddaloni E
    Nat Rev Endocrinol; 2017 Nov; 13(11):674-686. PubMed ID: 28885622
    [TBL] [Abstract][Full Text] [Related]  

  • 56. GADA titer-related risk for organ-specific autoimmunity in LADA subjects subdivided according to gender (NIRAD study 6).
    Zampetti S; Capizzi M; Spoletini M; Campagna G; Leto G; Cipolloni L; Tiberti C; Bosi E; Falorni A; Buzzetti R;
    J Clin Endocrinol Metab; 2012 Oct; 97(10):3759-65. PubMed ID: 22865904
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevalence and clinical characteristics of insulin-treated, anti-GAD-positive, type 2 diabetic subjects in an outpatient clinical department of a Dutch teaching hospital.
    Römkens TE; Kusters GC; Netea MG; Netten PM
    Neth J Med; 2006 Apr; 64(4):114-8. PubMed ID: 16609158
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Similar genetic features and different islet cell autoantibody pattern of latent autoimmune diabetes in adults (LADA) compared with adult-onset type 1 diabetes with rapid progression.
    Hosszúfalusi N; Vatay A; Rajczy K; Prohászka Z; Pozsonyi E; Horváth L; Grosz A; Gerõ L; Madácsy L; Romics L; Karádi I; Füst G; Pánczél P
    Diabetes Care; 2003 Feb; 26(2):452-7. PubMed ID: 12547879
    [TBL] [Abstract][Full Text] [Related]  

  • 59. LADA prevalence estimation and insulin dependency during follow-up.
    Park Y; Hong S; Park L; Woo J; Baik S; Nam M; Lee K; Kim Y;
    Diabetes Metab Res Rev; 2011 Nov; 27(8):975-9. PubMed ID: 22069296
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical and metabolic profile of patients with latent autoimmune diabetes in adults in specialized care in Madrid.
    Arranz Martín A; Lecumberri Pascual E; Brito Sanfiel MÁ; Andía Melero V; Nattero Chavez L; Sánchez López I; Cánovas Molina G; Arrieta Blanco F; González Perez Del Villar N;
    Endocrinol Diabetes Nutr; 2017 Jan; 64(1):34-39. PubMed ID: 28440768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.